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ABSTRACT
Hemophagocytic lymphohistiocytosis (HLH) is an uncommon life-threatening 
disorder characterized by wide spread non-neoplastic proliferation and 
inappropriate activation of mature macrophages resulting in hypercytokinemia. 
This uncontrollable and ineffective systemic immune response causes fever, 
hepatosplenomegaly, cytopenias and subsequently multiorgan failure. The 
authors report a case of a 41-year-old male patient with a 30-day history of 
weight loss, fever, icterus, hepatomegaly, and cytopenias. The diagnostic 
workup disclosed hypertriglyceridemia, hypofibrinogenemia, and elevated 
ferritin. Bone marrow examination and clinical course raised the suspicion of 
HLH and treatment was started with high-dose corticosteroids and immune 
globulin. The patient underwent multi-organ failure and expired after 58 days of 
hospitalization. The autopsy finding included massive bone marrow infiltration 
by non-neoplastic histiocytes, many of them showing hemophagocytosis, 
which immunohistochemical study revealed diffuse CD68-positive histiocytes, 
which were negative for S100 protein. Hemophagocytosis was also observed 
in the lungs, lymph nodes and liver. The immediate cause of death was 
attributed to a massive intestinal bleeding due to extensive ischemic necrosis 
at the duodenum/jejunal transition area.
Keywords: Hemophagocytic syndrome; Hemophagocytic lymphohistiocytosis; Macrophage 
activation; Autopsy.
CASE REPORT
A 41-year-old male patient sought medical 
attention complaining of daily high-grade fever 
accompanied by night sweats and 20 kg of weight 
loss during the last month. He reported that he was 
experiencing anorexia, asthenia, and progressive 
lower-limb weakness and recently noted jaundice. 
His past medical history included hypertension. 
He used to drink a lot of alcohol in the past, still 
smokes and was taking captopril regularly. Physical 
examination upon admission showed an apparently 
healthy man, febrile, slightly dehydrated, and 
icteric. His blood pressure = 120 / 75 mmHg, 
pulse rate = 106 beats per minute, respiratory 
rate = 18 respiratory movements per minute, axillary 
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requiring vasopressors and mechanical ventilation. 
Supportive care involved frequent red cell, platelets, 
and plasma transfusions. The revision of the 
bone marrow aspirate hemophagocytosis was 
detected, which raised the possibility of a diagnosis 
of hemophagocytic lymphohistiocytosis (HLH). 
High-dose methylprednisolone (1 g/day for 3 days) 
was started in conjunction with gamma globulin 
therapy 30 g/day for 5 days as well as broad-spectrum 
antibiotics. A slight clinical improvement was 
observed. On day 25 of hospitalization, the 
patient underwent a splenectomy and liver biopsy. 
The procedures were undertaken to confirm the 
diagnosis as well as to definitively exclude the 
diagnostic possibility of lymphoid malignancy.
The splenic pathologic examination revealed 
massive infiltration of the splenic sinusoids by 
plump phagocytic histiocytes, associated with 95% 
of ischemic necrosis of the splenic parenchyma and 
atrophy of the residual white pulp (Figure 1). The 
liver biopsy revealed Kupffer cell hyperplasia as 
well as hemophagocytosis.
Cyclosporine could not be started once the 
patient developed septicemia. The patient died on 
day 58 of hospitalization. An autopsy was performed.
AUTOPSY
Among the autopsy findings, histopathological 
examination revealed massive bone marrow 
infiltration by non-neoplastic histiocytes, many of 
them showing hemophagocytosis (the presence of 
red blood cells, granulocytes and their precursors, 
body temperature = 38 °C, body mass index = 21.6. 
Peripheral lymph node enlargement was not 
detected. Thorax examination showed the presence 
of a mild systolic murmur in the mitral valve area, 
and the lung examination was normal. Abdominal 
examination showed a palpable liver 1 cm below the 
right costal margin, as well as painful splenomegaly 
5 cm below the left costal margin. The remainder of 
the physical examination was unremarkable.
Initial laboratory workup is shown in Table 1 
and Table 2 summarizes the etiologic investigation.
The upper gastrointestinal endoscopy 
disclosed an enanthematic pangastritis. 
Echocardiography was normal. Abdominal 
ultrasonography showed a splenomegaly with 
hypoechoic areas within the splenic parenchyma, 
confirmed by the abdominal computed tomography.
The bone marrow aspiration showed 
hypercellularity at the expense of the granulocytic 
series, confirmed on the bone marrow biopsy, which 
also showed hyperplasia of the megakaryocytic 
series. On this biopsy, the presence a micro 
granuloma was also depicted. The Ziehl-Neelsen, 
Grocott and PAS staining failed to show the 
presence of acid-fast bacilli and fungi. The bone 
marrow immunophenotyping did not detect any 
evidence of lymphoma.
During hospitalization, the patient remained 
febrile, presented worsening hepatic function, and 
renal failure demanding hemodialysis. Clinical 
status was complicated even more with respiratory 
failure related to presumed pulmonary infection 
Table 1 – Initial laboratory examination work up
Exam Result RV Exam Result RV
Hemoglobin 14.8 12.3-15.3 g/dL AST 443 10-31 U/L
Hematocrit 43.7 36.0-45.0% ALT 404 9-36 U/L
Leukocytes 4.78 4.4-11.3.10³/mm3 Alkaline phosphatase 719 10-100 U/L
Rods 0 1-5% γGT 368 2-30 U/L
Segmented 55 46-75% Total bilirubin 9.6 0.3-1.2 mg/dL
Eosinophil 0 1-4% LDH 1274 120-246 U/L
Basophil 2 0-2.5% INR 1.69 1
Lymphocyte 31 18-40% Fibrinogen 67 175-400 mg/dL
Monocyte 12 2-9% Triglycerides 617 <150 mg/dL
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was positive in small clusters of B-lymphocytes and 
rare in interstitial lymphocytes; CD3, CD2, and CD5 
were positive in interstitial small T-lymphocytes. No 
other malignancy was present. The histological and 
immunohistochemical findings observed in the bone 
marrow were similar to the previous bone marrow 
biopsy performed during hospitalization.
Hemophagocytosis was also observed in 
the lungs where the histiocytes were detected in 
the alveolar lumen (Figure 3). The lymph nodes 
exhibited hemophagocytosis associated with 
lymphoid depletion (Figure 4).
The examination of the liver also showed 
the diffuse presence of hemophagocytic histiocytes 
throughout the hepatic sinusoids (Figure 5). 
Extensive areas of ischemic centrilobular necrosis, 
probably related to the septic shock, were also 
observed.
The examination of the remaining organs 
revealed pathological changes associated with 
platelet debris as well as lymphocytes encompassed 
into the cytoplasm of the activated histiocytes) 
(Figure 2). The immunohistochemical study revealed 
diffuse CD68-positive histiocytes, which were 
negative for S100 protein. Other markers were used 
to evaluate the hematopoietic series and to rule out 
the presence of lymphomatous infiltration. CD20 
Table 2 – Serologic investigation
Exam Result
Anti-HIV Negative
Anti-CMV (IgG and IgM) Negative





Anti-S. mansoni (IgM) Negative
Rheumatoid Factor <15 UI/mL
ANF (Hep 2) Negative
Figure 1 – Photomicrography of the spleen. A - Ischemic necrosis of the splenic parenchyma and atrophy of 
the residual white pulp (HE, 100X); B - Massive infiltration of the splenic sinusoids by phagocytic histiocytes 
(arrow, with a hematologic precursor cell inside the cytoplasm) (HE 400X); C - Immunohistochemical reaction 
reveals the CD68 positive histiocytes (Immunoperoxidase for CD 68).
Figure 2 – Photomicrography of the bone marrow. A - Panoramic view of bone marrow shows hypercellularity 
(HE 100X); B - Massive bone marrow infiltration by non-neoplastic histiocytes, many of them showing 
hemophagocytosis (HE, 400X); C - Immunohistochemical reaction reveals the CD68 positive histiocytes 
(Immunoperoxidase for CD 68).
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infarction, and hemorrhage of the adrenal gland 
cortex, foci of ischemic necrosis of pancreatic acini, 
ischemic pituitary infarct, and skin ulcerations.
DISCUSSION
The term hemophagocytosis describes 
the pathologic finding of activated macrophages, 
engulfing erythrocytes, leukocytes, platelets, 
and their precursor cells. This phenomenon is an 
important finding in patients with hemophagocytic 
syndrome (HS), also known as hemophagocytic 
lymphohistiocytosis (HLH). This rare and frequently 
fatal disorder is characterized by unregulated 
Figure 3 – Photomicrography of the lung. A - The alveolar lumen shows many histiocytes. (HE, 200X); 
B - Hemophagocytosis (arrow) (HE, 1000X).
Figure 4 – Photomicrography of the lymph nodes. A - Lymphoid depletion. (HE, 200X); B - Histiocytes in the 
lymph node sinuses show hemophagocytosis (arrows) (HE, 400X).
infection and septic shock. The lungs were 
congested; the right lung weighted 639.0 g 
(reference value RV = 450.0 g) and the left lung 
weighted 432.0 g (RV = 375.0 g). Microscopically, 
intra-alveolar edema and massive congestion were 
present, as well as hemophagocytic histiocytes into 
the alveolar lumen. Ischemic injuries were found in 
many organs, very likely due to the septic shock. 
The duodenum/jejunal transition area showed 
extensive mucosal injury and diffuse bleeding, with 
a large amount (estimated at 500 g) of clots in the 
small intestine lumen. Its microscopic examination 
showed ischemic necrosis of the mucosa exhibiting 
massive intestinal bleeding, which was interpreted 
as the immediate cause of death (Figure 6). The 
autopsy also revealed acute renal tubular necrosis, 
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proliferative syndrome, in which the HLH may 
develop.3 In FHLH, the onset of the disease occurs 
in 70-80% of cases below 1 year of age, although 
several late-onset cases have been reported.4,5 The 
acquired, or secondary HLH was first described by 
Risdall in 1979 and occurs in all age groups.6 The 
leading triggering agents in secondary HLH are 
viruses of the herpes group, especially Epstein-Barr 
virus (EBV) and cytomegalovirus (CMV). Other 
examples include varicella zoster virus,7 human 
herpesvirus (HHV)-6,8 and HHV-8,9 HIV,10 Rubella,11 
adenovirus,12 parvovirus,8 hepatitis B virus,13 and 
avian influenza.14 The latter is a particularly potent 
stimulus for hemophagocytic reactions in Asia, 
probably associated with the high mortality observed 
in that infection. Other microbial pathogens 
include Mycobacterium tuberculosis,15 Serratia 
marcenses,16 Burkholderia cepacia,17 and fungal 
infections such as candidiasis,18 aspergillosis,19 and 
histoplasmosis.20 The identification of an infectious 
organism does not necessarily discriminate between 
the genetic and acquired form of HLH, since most 
episodes in genetic HLH may also be triggered by 
infections.21
Acquired HLH has also been reported, mostly 
in adults, in association with malignant diseases 
especially lymphomas, lymphoma-associated 
hemophagocytic syndrome (LAHS). In Japan, the 
EBV genome was detected in more than 80% of 
patients with T/NK cell lymphoma.22 The EBV-infected 
T/NK cells seem to play a major role in the 
development of LAHS, as well as in EBV-associated 
HLH without lymphoma.23 The HLH that occurs in 
association with autoimmune diseases is called 
macrophage-activation syndrome (MAS) and is 
activation of the immune system, resulting in a 
systemic inflammatory response syndrome (SIRS).1 
Although rare, increased awareness of these 
conditions has led to more frequent diagnoses.
HLH occurs in all age groups and is classified 
in two major forms: genetic or primary, and acquired 
or secondary. Farquhar and Claireux from the 
University of Edinburgh are credited with the first 
description of genetic HLH in 1952, which they 
named after “familial hemophagocytic reticulosis.”2 
This genetic or primary HLH is inherited in an 
autosomal recessive or x-linked manner and is 
divided into a) familial HLH (FHLH) in which the 
clinical syndrome of HLH is the only manifestation; 
and b) the immune deficiencies like Chédiak-
Higashi syndrome, Griscelli syndrome, and x-linked 
Figure 5 – Photomicrography of the liver. A - Diffuse 
presence of hemophagocytic histiocytes throughout 
the hepatic sinusoids (HE, 400X); B - Detail (HE, 
1000X).
Figure 6 – Duodenum/jejunal transition. A - Gross examination reveal extensive mucosal injury with diffuse 
bleeding, with large amount of clots into the small intestine lumen; B - Photomicrography of the small intestine 
showing ischemic necrosis of the mucosa (HE, 200X).
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diagnosis of the case presented here. This disorder 
was previously called true Histiocytic Lymphoma 
or Malignant Histiocytosis, but as they were 
subsequently shown to be lymphomas, generally 
of T-cell origin, these terms were no longer used. 
In contrast to HLH, patients with HS present 
tumoral skin lesions (solitary or multiple), bone lytic 
lesions and primary tumors in the central nervous 
system. On the other hand, HLH is characterized by 
diffuse, rather than localized, histiocytic infiltration. 
The histopathology of HS shows lymph node 
involvement by malignant cells similar to histiocytes 
and the visceral organ involvement may exhibit a 
sinusal pattern. Hemophagocytosis is seldom seen 
in the tumor cells, which show large pleomorphic 
nuclei and variable mitotic activity26.
The incidence of HLH in adults is unknown. 
The disorder is believed to be underdiagnosed, 
and most reported studies are related to children. 
In the case of the primary autosomal recessive 
form, also known as familial hemophagocytic 
lymphohistiocytosis (FHL), the incidence is 
estimated at 1:50,000 live born children.29
The supposed pathophysiology of HLH 
is an uncontrolled stimulation of histiocytes 
(macrophages and dendritic cells), natural killer 
(NK) cells, cytotoxic T lymphocytes (CTLs) leading 
to persistent hypercytokinemia and systemic 
inflammatory response syndrome (SIRS).25 In 
patients with hemophagocytic syndrome, splenic 
macrophages appear to be activated, as evidenced 
by increased expression of major histocompatibility 
complex Class I (MHC-I) and MHC-II molecules, as 
well as the macrophage colony-stimulating factor 
receptor.30 Once triggered by an infectious agent, 
histiocytes (macrophages and dendritic cells), 
NK cells, and CTLs are activated and mutually 
stimulate each other. NK cells and CTLs kill their 
targets through cytolytic vesicles containing perforin 
and granzyme. The cytolytic vesicles are formed in 
the killer cells, fuse with the plasma membrane and 
release their content in the immunological synapse, 
which is formed upon contact between the killer and 
the target cells.31 This sequence of events ends 
with the killing of the offending agent, removal of the 
antigen, and termination of the immune response. 
Deficient cytotoxic activity impairs the elimination 
of cellular targets, expressing antigens and the 
down-regulation of the immune response as well. 
This process may be compromised by defects 
caused by mutations and will be responsible for the 
inherited or primary HLH.
now considered a special form of HLH occurring in 
patients with juvenile rheumatoid arthritis, systemic 
erythematous lupus, Behcet’s syndrome and other 
entities. The MAS has many characteristic features 
of HLH, but cytopenias may be less severe, cardiac 
impairment appears to be more common and 
coagulopathy more pronounced.24,25 In the case 
reported here, the laboratory workup failed to point 
out a triggering etiological agent, and the autopsy 
failed to reveal evidence of a lymphoma.
The differential diagnosis of non-neoplastic 
proliferation of histiocytes, regarding 
histopathological features, includes (Table 3).
Sinus histiocytosis with massive 
lymphadenopathy (SHML), also known as 
Rosai-Dorfman Disease deserves special attention 
in the differential diagnosis of this case. This 
disorder is characterized by massive bilateral 
enlargement of cervical lymph nodes, which show, 
in the histological examination, sinuses expansion 
by large histiocytes, lymphocytes and plasma cells. 
The histiocytes show intracytoplasmic vacuoles 
with the presence of lymphocytes and plasma 
cells, a process called emperipolesis, as well as 
erythrophagocytosis.26 Unlike the HLH, however, 
the histiocytes in the SHML express S-100, what 
was negative in the present case, permitting the 
exclusion of this diagnostic possibility. HLH, mainly 
in the familial form, occurring in early life, can mimic 
SHML. The pathologic features of the HLH are 
characterized by lymphoid depletion and massive 
sinusoidal infiltration by histiocytes. Contrasting 
with SHML, hemophagocytic syndromes present 
as a disseminated disease of aggressive clinical 
course 26, occasionally seen in the SHML27.
The Histiocytic Sarcoma (HS), a malignant 
proliferation of cells with morphologic and 
immunophenotypic features of mature tissue 
histiocytes28 could be consider in the differential 
Table 3 – Non-neoplastic histiocytic proliferations26
(1) Reactive sinus histiocytosis
(2) Sinus histiocytosis with massive lymphadenopathy 
(Rosai-Dorfman)
(3) Hemophagocytic syndromes:
3.a - Familial hemophagocytic lymphohistiocytosis
3.b - Secondary hemophagocytic syndromes
(4) Storage disorders
4.a - Niemann-Pick disease
4.b - Gaucher’s disease
4.c - Tangier disease
17
Hemophagocytic lymphohistiocytosis of indeterminate cause: a fatal adult case Autopsy and Case Reports 2012; 2(2): 11-20
The symptoms of HLH can be explained by high 
concentrations of cytokines and organ infiltration 
by activated lymphocytes and histiocytes.30 
Ongoing hypercytokinemia is a reflection of the 
failure of natural immune down-regulation due to 
defective NK and CTL function.25 Fever is induced 
by interleukin-1 (IL-1) and IL-6, and pancytopenia 
is rather the consequence of high levels of TNF-α 
and interferon γ, than of hemophagocytosis. TNF-α 
inhibits lipoprotein lipase leading to elevated 
triglycerides. Activated macrophages not only 
secrete ferritin but also plasminogen activators, 
which results in high plasmin levels and hyper 
fibrinolysis, hepatosplenomegaly, increased liver 
enzymes and bilirubin.3 The Histiocyte Society 
created diagnostic guidelines in 1991, based on 
common clinical, laboratory, and histopathological 
findings. This guideline was revised keeping the five 
criteria of the 1991 guidelines but introducing three 
additional criteria. The diagnostic criteria for HLH 
are summarized in Table 4.
A recent review undertaken in a pediatric 
hospital concerning elevated ferritin results showed 
that ferritin levels greater than 10,000 mcg/dL 
were 90% sensitive and 96% specific for HLH 
diagnosis.35 Although hemophagocytosis in biopsy 
specimens is the hallmark of HLH, the absence of 
this finding should not hinder the physician from 
starting treatment if other diagnostic criteria are 
met. It is not uncommon to require more than one 
biopsy specimen to demonstrate this microscopic 
evidence. On the other hand, the mere presence of 
hemophagocytosis in the reticuloendothelial system 
is not implied in the diagnosis, once it also occurs 
in other disorders.1,21 Some valuable diagnostic 
and disease markers are: increased concentrations 
of IL-2 receptor (sCD25) and decreased NK 
cell function, b-2 microglobulin,31 macrophage 
inflammatory protein-1a (MIP-1a)36 and CD163.37
In the diagnostic work up for infectious 
agent, searching for EBV, CMV, herpes simplex 
virus, adenovirus, parvovirus B19, and others are 
recommended. The patient should be screened 
for underlying immune deficiency, autoimmune 
diseases, and malignancies.
Since HLH masquerades as a normal 
infection, the diagnosis is frequently challenging. 
Time may then be lost with extensive workup for 
an infectious disease and consequently prolonged 
antibiotic therapy. Ferritin, fibrinogen, and 
triglycerides are not routinely determined in patients 
with fever, and the absence of hemophagocytosis, 
Currently, nine genetic disorders have been 
described as related to the diagnosis of HLH in 
children; many familial cases still await molecular 
definition.25 Abnormalities in the function (but rarely 
in the quantity) of NK cells have been observed in 
patients with all forms of HLH.25 Sustained immune 
activation with persistent high cytokine levels will be 
responsible for the clinical picture of HLH. Studies of 
cytokine levels in blood and tissues have indicated 
persistently elevated circulating levels of multiple 
proinflammatory cytokines during symptomatic 
disease.25 It is not fully clear how apparently 
immunocompetent patients develop dysfunction of 
NK cells and CTLs following triggering events, such 
as viral infections. In the case of EBV infection, it 
is believed that instead of affecting B-lymphocytes, 
as usual, the virus infects NK-T cells, stimulating 
their proliferation with subsequent production 
of proinflammatory cytokines, particularly tumor 
necrosis factor-α (TNF-α) and interferon-γ, through 
the stimulation by EBV latent-membrane-protein 
1 (LMP-1). This hypercytokinemia stimulates 
macrophages leading to the HLH. EBV infection 
has also been implicated in the pathogenesis of 
LAHS—the latter being a continuum of the natural 
progression of T-cell infection with EBV. Some 
patients diagnosed with EBV-associated HLH who 
survived have been observed to progress to T-cell 
lymphoma. Latent-membrane-protein 1 is believed 
to protect the EBV-infected T cells against the 
TNF-α-induced apoptosis. These cells are thought 
to survive and can later cause a relapse of the 
disease.1 Chromosome analysis of EBV-infected 
T-cells in patients with HLH showed clonality 
early in the course of the disease, accounting for 
further progression to lymphoma.32 Viruses may 
interfere with CTL function by specific proteins; 
high levels of cytokines may have the same effect. 
The high prevalence of EBV-associated HLH in 
Asia also suggests a genetic basis. In patients with 
lymphomas, secretion of cytokines by the malignant 
cells is a possible explanation.3
The clinical and laboratory findings of HLH 
consist in prolonged fever, hepatosplenomegaly, and 
cytopenias, and less frequently, lymphadenopathy, 
rash, icterus, and neurological symptoms, many 
of them observed in the patient reported here. 
Characteristic laboratory alterations include high 
levels of triglycerides, ferritin, liver enzymes, 
bilirubin, lactate dehydrogenase, and low fibrinogen 
due to endothelial activation/coagulopathy, as 
observed in our patient.24,25 A hallmark of HLH, no 
matter if in genetic or acquired form, is the impaired 
or absent function of NK and cytotoxic-T cells. The 
number of NK cells may be normal or decreased.33 
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the splenectomy showed benefit and considered the 
splenectomy as a diagnostic aiding tool for HLH.40
HLH is still overlooked since the clinical 
symptoms are similar to infections found in immune 
competent patients. Hemophagocytosis does not 
have to be present in the initial diagnostic workup. 
Patients with prolonged fever, unresponsive 
to antibiotics, accompanied by pronounced 
hepatosplenomegaly and cytopenias should be 
highly considered in the differential diagnosis of 
HLH. Due to the severity of the disease, clinical 
suspicion has to be followed by exhaustive search 
for the precise diagnosis and early institution of 
therapy.
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